BIODELIVERY SCIENCES INTERNATIONAL INC 4 SEC Filings

Filed On	Filing
22 Mar 2022	Form 4: Watson W. Mark, Director Disposed of 90,663 shares (Other Transaction) · Disposed of 22,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 140,500 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Vollins James, See Remarks Disposed of 91,401 Restricted Stock Units (Disposition to Issuer) · Disposed of 706,967 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Singh Vanila, Director Disposed of 35,851 shares (Other Transaction) · Disposed of 17,019 Restricted Stock Units (Disposition to Issuer) · Disposed of 214,768 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Smith Thomas B, Chief Medical Officer Disposed of 52,530 shares (Other Transaction) · Disposed of 88,719 Restricted Stock Units (Disposition to Issuer) · Disposed of 794,071 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Sirgo Mark A, Director Disposed of 1,166,866 shares (Other Transaction) · Disposed of 11,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 204,260 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Plesha Scott M., See Remarks Disposed of 345,127 shares (Other Transaction) · Disposed of 119,228 Restricted Stock Units (Disposition to Issuer) · Disposed of 962,943 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Kotler Kevin, Director and 2 others Disposed of 7,588,395 shares (Other Transaction) · Disposed of 22,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 93,260 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Golubieski John, See Remarks Disposed of 126,199 Restricted Stock Units (Disposition to Issuer) · Disposed of 706,666 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Greenleaf Peter, Director Disposed of 105,034 shares (Other Transaction) · Disposed of 27,746 Restricted Stock Units (Disposition to Issuer) · Disposed of 178,511 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Davis Todd C, Director Disposed of 252,207 shares (Other Transaction) · Disposed of 22,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 133,883 Stock Options (right to buy) (Disposition to Issuer)
22 Mar 2022	Form 4: Bailey Jeffrey Allen, Director Disposed of 105,133 shares (Other Transaction) · Disposed of 316,919 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,306,272 Stock Options (right to buy) (Disposition to Issuer)
11 Mar 2022	Form 4: Bailey Jeffrey Allen, Director Received 5,333 shares by exercise or conversion
15 Feb 2022	Form 4: Kotler Kevin, Director and 2 others Received 2,422,222 shares by conversion ($4.36M)
08 Feb 2022	Form 4: Vollins James, See Remarks Sold 18,541 shares ($66.7K) · Gave up 9,872 shares to cover exercise price or tax ($36.1K)
01 Feb 2022	Form 4: Davis Todd C, Director Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) ($314K) · Granted 15,369 Restricted Stock Units
31 Jan 2022	Form 4: Watson W. Mark, Director Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) ($314K) · Granted 15,369 Restricted Stock Units
31 Jan 2022	Form 4: Singh Vanila, Director Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) · Granted 15,369 Restricted Stock Units
31 Jan 2022	Form 4: Sirgo Mark A, Director Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) · Granted 15,369 Restricted Stock Units
31 Jan 2022	Form 4: Kotler Kevin, Director and 2 others Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) · Granted 15,369 Restricted Stock Units
31 Jan 2022	Form 4: Greenleaf Peter, Director Received 10,246 shares by exercise or conversion · Granted 114,347 Stock Options (right to buy) ($419K) · Granted 20,492 Restricted Stock Units

22 Mar 2022

Disposed of 90,663 shares (Other Transaction) · Disposed of 22,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 140,500 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Vollins James, See Remarks

Disposed of 91,401 Restricted Stock Units (Disposition to Issuer) · Disposed of 706,967 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Singh Vanila, Director

Disposed of 35,851 shares (Other Transaction) · Disposed of 17,019 Restricted Stock Units (Disposition to Issuer) · Disposed of 214,768 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Smith Thomas B, Chief Medical Officer

Disposed of 52,530 shares (Other Transaction) · Disposed of 88,719 Restricted Stock Units (Disposition to Issuer) · Disposed of 794,071 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Sirgo Mark A, Director

Disposed of 1,166,866 shares (Other Transaction) · Disposed of 11,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 204,260 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Plesha Scott M., See Remarks

Disposed of 345,127 shares (Other Transaction) · Disposed of 119,228 Restricted Stock Units (Disposition to Issuer) · Disposed of 962,943 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Kotler Kevin, Director and 2 others

Disposed of 7,588,395 shares (Other Transaction) · Disposed of 22,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 93,260 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Golubieski John, See Remarks

Disposed of 126,199 Restricted Stock Units (Disposition to Issuer) · Disposed of 706,666 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Greenleaf Peter, Director

Disposed of 105,034 shares (Other Transaction) · Disposed of 27,746 Restricted Stock Units (Disposition to Issuer) · Disposed of 178,511 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Davis Todd C, Director

Disposed of 252,207 shares (Other Transaction) · Disposed of 22,685 Restricted Stock Units (Disposition to Issuer) · Disposed of 133,883 Stock Options (right to buy) (Disposition to Issuer)

22 Mar 2022

Form 4: Bailey Jeffrey Allen, Director

Disposed of 105,133 shares (Other Transaction) · Disposed of 316,919 Restricted Stock Units (Disposition to Issuer) · Disposed of 2,306,272 Stock Options (right to buy) (Disposition to Issuer)

11 Mar 2022

Form 4: Bailey Jeffrey Allen, Director

Received 5,333 shares by exercise or conversion

15 Feb 2022

Form 4: Kotler Kevin, Director and 2 others

Received 2,422,222 shares by conversion ($4.36M)

08 Feb 2022

Form 4: Vollins James, See Remarks

Sold 18,541 shares ($66.7K) · Gave up 9,872 shares to cover exercise price or tax ($36.1K)

01 Feb 2022

Form 4: Davis Todd C, Director

Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) ($314K) · Granted 15,369 Restricted Stock Units

31 Jan 2022

Form 4: Watson W. Mark, Director

Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) ($314K) · Granted 15,369 Restricted Stock Units

31 Jan 2022

Form 4: Singh Vanila, Director

Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) · Granted 15,369 Restricted Stock Units

31 Jan 2022

Form 4: Sirgo Mark A, Director

Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) · Granted 15,369 Restricted Stock Units

31 Jan 2022

Form 4: Kotler Kevin, Director and 2 others

Received 7,684 shares by exercise or conversion · Granted 85,760 Stock Options (right to buy) · Granted 15,369 Restricted Stock Units

31 Jan 2022

Form 4: Greenleaf Peter, Director

Received 10,246 shares by exercise or conversion · Granted 114,347 Stock Options (right to buy) ($419K) · Granted 20,492 Restricted Stock Units